Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 13 10 2021
accepted: 23 03 2022
entrez: 14 4 2022
pubmed: 15 4 2022
medline: 19 4 2022
Statut: epublish

Résumé

Infections caused by Fusobacterium species are rare; however serious infections with complications or mortality may occur occasionally. We conducted a retrospective study to investigate the clinical features of patients with Fusobacterium infections and the differences between infections caused by the species F. necrophorum, F. nucleatum, and F. varium. Additionally, we attempted to identify risk factors for Fusobacterium-associated mortality. This study included all patients at a large tertiary care teaching hospital in South Korea with Fusobacterium infections from January 2006 to April 2021. Demographic, clinical, laboratory, and outcome data were analyzed. Multiple logistic regression analysis was performed to assess the risk factors for in-hospital mortality associated with F. nucleatum and F. varium infections. We identified 272 patients with Fusobacterium infections during the study period. The number of Fusobacterium cases has increased recently, with F. varium infections markedly increasing since 2016 and causing a significant proportion of infections. Patients with F. varium infections were older and had a higher proportion of nosocomial infections than the other groups. The F. nucleatum and F. varium groups showed higher in-hospital mortality than the F. necrophorum group. Through logistic regression analysis, APACHE II score and serum albumin level were considered risk factors for in-hospital mortality. APACHE II score was positively correlated with age, red cell distribution width, and serum blood urea nitrogen, and negatively correlated with serum albumin level. Infections caused by Fusobacterium species are increasing. F. varium causes a significant proportion of severe infections.

Identifiants

pubmed: 35421136
doi: 10.1371/journal.pone.0266610
pii: PONE-D-21-32831
pmc: PMC9009667
doi:

Substances chimiques

Serum Albumin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0266610

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infection. 2014 Apr;42(2):363-70
pubmed: 24326987
JAMA Oncol. 2015 Aug;1(5):653-61
pubmed: 26181352
Anaerobe. 2019 Jun;57:82-85
pubmed: 30951829
Clin Infect Dis. 2007 Apr 1;44(7):895-900
pubmed: 17342637
Clin Infect Dis. 1997 Sep;25 Suppl 2:S181-3
pubmed: 9310671
Curr Opin Microbiol. 2015 Feb;23:141-7
pubmed: 25576662
J Foot Ankle Surg. 2016 Sep-Oct;55(5):1087-90
pubmed: 26456575
BMC Infect Dis. 2013 Jun 05;13:264
pubmed: 23734900
World J Gastroenterol. 2016 Jan 14;22(2):557-66
pubmed: 26811607
Nat Rev Microbiol. 2019 Mar;17(3):156-166
pubmed: 30546113
Diagn Microbiol Infect Dis. 2011 Jun;70(2):167-74
pubmed: 21596220
JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181-193
pubmed: 30288759
J Microbiol Immunol Infect. 2020 Aug;53(4):513-517
pubmed: 32303484
J Microbiol Immunol Infect. 2009 Aug;42(4):336-42
pubmed: 19949758
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Infect. 2008 Oct;57(4):283-9
pubmed: 18805588
Am J Gastroenterol. 2010 Aug;105(8):1820-9
pubmed: 20216533
Infection. 2016 Aug;44(4):475-81
pubmed: 26783023
Expert Opin Pharmacother. 2011 Aug;12(11):1691-707
pubmed: 21506900
J Clin Microbiol. 2005 Aug;43(8):4293-5
pubmed: 16082005
J Med Microbiol. 2009 May;58(Pt 5):535-545
pubmed: 19369513
Anaerobe. 2015 Aug;34:120-4
pubmed: 25988544
Clin Microbiol Infect. 2020 Aug;26(8):1089.e7-1089.e12
pubmed: 31843654

Auteurs

Se Ju Lee (SJ)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Yae Jee Baek (YJ)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Jin Nam Kim (JN)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Ki Hyun Lee (KH)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Eun Hwa Lee (EH)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Joon Sup Yeom (JS)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Jun Yong Choi (JY)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Nam Su Ku (NS)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Jin Young Ahn (JY)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Jung Ho Kim (JH)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Su Jin Jeong (SJ)

Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Seoul, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH